Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.

Dexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR). Our aim was to determine the effects of dexamethasone treatment on wild-t...

Full description

Bibliographic Details
Main Authors: Luiz Felipe M Prota, Liudmila Cebotaru, Jie Cheng, Jerry Wright, Neeraj Vij, Marcelo M Morales, William B Guggino
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3521767?pdf=render
_version_ 1818016276695482368
author Luiz Felipe M Prota
Liudmila Cebotaru
Jie Cheng
Jerry Wright
Neeraj Vij
Marcelo M Morales
William B Guggino
author_facet Luiz Felipe M Prota
Liudmila Cebotaru
Jie Cheng
Jerry Wright
Neeraj Vij
Marcelo M Morales
William B Guggino
author_sort Luiz Felipe M Prota
collection DOAJ
description Dexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR). Our aim was to determine the effects of dexamethasone treatment on wild-type CFTR expression.Dose-response (1 nM to 10 µM) and time course (3 to 48 h) curves were generated for dexamethasone for mRNA expression in Calu-3 cells using a real-time PCR. Within 24 h, dexamethasone (10 nM) showed a 0.3-fold decrease in CFTR mRNA expression, and a 3.2-fold increase in αENaC mRNA expression compared with control groups. Dexamethasone (10 nM) induced a 1.97-fold increase in the total protein of wild-type CFTR, confirmed by inhibition by mifepristone. To access surface protein expression, biotinylation followed by Western blotting showed that dexamethasone treatment led to a 2.35-fold increase in the amount of CFTR in the cell surface compared with the untreated control groups. Once protein translation was inhibited with cycloheximide, dexamethasone could not increase the amount of CFTR protein. Protein stability was assessed by inhibition of protein synthesis with cycloheximide (50 µg/ml) at different times in cells treated with dexamethasone and in untreated cells. Dexamethasone did not alter the degradation of wild-type CFTR. Assessment of the B band of CFTR within 15 min of metabolic pulse labeling showed a 1.5-fold increase in CFTR protein after treatment with dexamethasone for 24 h. Chaperone 90 (HSP90) binding to CFTR increased 1.55-fold after treatment with dexamethasone for 24 h, whereas chaperone 70 (HSP70) binding decreased 0.30 fold in an immunoprecipitation assay.Mature wild-type CFTR protein is regulated by dexamethasone post transcription, involving cotranslational mechanisms with HSP90 and HSP70, which enhances maturation and expression of wild-type CFTR.
first_indexed 2024-04-14T07:10:00Z
format Article
id doaj.art-15fe5662c62349278a73f19385200a54
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T07:10:00Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-15fe5662c62349278a73f19385200a542022-12-22T02:06:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e4740510.1371/journal.pone.0047405Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.Luiz Felipe M ProtaLiudmila CebotaruJie ChengJerry WrightNeeraj VijMarcelo M MoralesWilliam B GugginoDexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR). Our aim was to determine the effects of dexamethasone treatment on wild-type CFTR expression.Dose-response (1 nM to 10 µM) and time course (3 to 48 h) curves were generated for dexamethasone for mRNA expression in Calu-3 cells using a real-time PCR. Within 24 h, dexamethasone (10 nM) showed a 0.3-fold decrease in CFTR mRNA expression, and a 3.2-fold increase in αENaC mRNA expression compared with control groups. Dexamethasone (10 nM) induced a 1.97-fold increase in the total protein of wild-type CFTR, confirmed by inhibition by mifepristone. To access surface protein expression, biotinylation followed by Western blotting showed that dexamethasone treatment led to a 2.35-fold increase in the amount of CFTR in the cell surface compared with the untreated control groups. Once protein translation was inhibited with cycloheximide, dexamethasone could not increase the amount of CFTR protein. Protein stability was assessed by inhibition of protein synthesis with cycloheximide (50 µg/ml) at different times in cells treated with dexamethasone and in untreated cells. Dexamethasone did not alter the degradation of wild-type CFTR. Assessment of the B band of CFTR within 15 min of metabolic pulse labeling showed a 1.5-fold increase in CFTR protein after treatment with dexamethasone for 24 h. Chaperone 90 (HSP90) binding to CFTR increased 1.55-fold after treatment with dexamethasone for 24 h, whereas chaperone 70 (HSP70) binding decreased 0.30 fold in an immunoprecipitation assay.Mature wild-type CFTR protein is regulated by dexamethasone post transcription, involving cotranslational mechanisms with HSP90 and HSP70, which enhances maturation and expression of wild-type CFTR.http://europepmc.org/articles/PMC3521767?pdf=render
spellingShingle Luiz Felipe M Prota
Liudmila Cebotaru
Jie Cheng
Jerry Wright
Neeraj Vij
Marcelo M Morales
William B Guggino
Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
PLoS ONE
title Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
title_full Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
title_fullStr Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
title_full_unstemmed Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
title_short Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90.
title_sort dexamethasone regulates cftr expression in calu 3 cells with the involvement of chaperones hsp70 and hsp90
url http://europepmc.org/articles/PMC3521767?pdf=render
work_keys_str_mv AT luizfelipemprota dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT liudmilacebotaru dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT jiecheng dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT jerrywright dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT neerajvij dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT marcelommorales dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90
AT williambguggino dexamethasoneregulatescftrexpressionincalu3cellswiththeinvolvementofchaperoneshsp70andhsp90